To retrospectively investigate the safety and oncological outcomes of cryoablation performed on residual/recurring renal cell carcinoma (RCC) in the ipsilateral kidney following partial nephrectomy (PN).
Data dealing with patients', RCC, procedure (including the length of the hospital stay), and follow-up (technical efficacy [TE], local tumor progression-free survival [LTPFS], disease-free survival [DFS], metastasis-free survival [MFS], cancer-specific survival (CSS), and overall survival [OS]) were retrospectively collected and analyzed.
Between January 2008 and November 2020, 21 consecutive patients (17 [81%] men; 4 [19%] women; median age 68 years; range 43-82) underwent cryoablation due to residual/recurring RCC in the PN site (15 patients) or de-novo RCC (6 patients) in the ipsilateral kidney. Median tumor size was 2.2 cm (mean 2.3 cm; range 0.8-4; interquartile range [IQR] 1.9-3). There were two (2/21; 10%) minor self-limiting hemorrhagic complications, both occurring in the group of patients with RCC in the PN site. Median hospital stay was 2 days (mean 2.1; range 1-5; IQR 2-2). TE was 100% (21/21 patients), and 10-year estimates of LTPFS, MFS and DFS were 74.1% (95% confidence intervals [CI] 56.8-96.7%), 36.4% (95% CI 14.2-93.8%), and 43.5% (95% CI 21.9-86.4%), respectively. CSS and OS were 100% at the last available follow-up (median 56 months; mean 67.4; range: 12-147; IQR:34-95).
Cryoablation in patients with residual/recurring RCC following PN is safe and results in high 10-year estimates of LTPFS.
Cardiovascular and interventional radiology. 2022 Mar 10 [Epub ahead of print]
Julien Rossi, Roberto Luigi Cazzato, Pierre de Marini, Pierre Auloge, Pierre-Alexis Autrusseau, Danoob Dalili, Thibault Tricard, Baptiste Poussot, Julien Garnon, Hervé Lang, Afshin Gangi
Department of Imaging, Service d'Imagerie, Lyon Sud Hospital, University Hospital of Lyon, Hospices Civils de Lyon, Lyon, France. ., Department of Interventional Radiology, University Hospital of Strasbourg, Strasbourg, France., Epsom and St Helier University Hospitals, London, UK., Department of Urology, University Hospital of Strasbourg, Strasbourg, France.